<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><label>Table 1.</label><caption><title>Criteria and human-based studies used in ToR-ORd calibration and validation.</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" valign="top">Calibration</th></tr></thead><tbody><tr><td valign="top">Action potential morphology</td><td valign="top">(<xref ref-type="bibr" rid="bib7">Britton et al., 2017</xref>; <xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Jost et al., 2013</xref>)</td></tr><tr><td valign="top">Calcium transient time to peak, duration, and amplitude</td><td valign="top">(<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>)</td></tr><tr><td valign="top">I-V relationship and steady-state inactivation of L-type calcium current</td><td valign="top">(<xref ref-type="bibr" rid="bib47">Magyar et al., 2000</xref>)</td></tr><tr><td valign="top">Sodium blockade is negatively inotropic</td><td valign="top">(<xref ref-type="bibr" rid="bib32">Gottlieb et al., 1990</xref>; <xref ref-type="bibr" rid="bib80">Tucker et al., 1982</xref>; <xref ref-type="bibr" rid="bib42">Legrand et al., 1983</xref>; <xref ref-type="bibr" rid="bib2">Bhattacharyya and Vassalle, 1982</xref>).</td></tr><tr><td valign="top">L-type calcium current blockade shortens the action potential</td><td valign="top">(<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>)</td></tr><tr><td valign="top">Early depolarisation formation under hERG block</td><td valign="top">(<xref ref-type="bibr" rid="bib34">Guo et al., 2011</xref>)</td></tr><tr><td valign="top">Alternans formation at rapid pacing</td><td valign="top">(<xref ref-type="bibr" rid="bib39">Koller et al., 2005</xref>)</td></tr><tr><td valign="top">Conduction velocity of ca. 65 m/s</td><td valign="top">(<xref ref-type="bibr" rid="bib74">Taggart et al., 2000</xref>)</td></tr><tr><th colspan="2" valign="top">Validation</th></tr><tr><td valign="top">Action potential accommodation</td><td valign="top">(<xref ref-type="bibr" rid="bib26">Franz et al., 1988</xref>)</td></tr><tr><td valign="top">S1-S2 restitution</td><td valign="top">(<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>)</td></tr><tr><td valign="top">Drug blocks and action potential duration</td><td valign="top">(<xref ref-type="bibr" rid="bib23">Dutta et al., 2017a</xref>; <xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>)</td></tr><tr><td valign="top">Hyperkalemia promotes postrepolarisation refractoriness</td><td valign="top">(<xref ref-type="bibr" rid="bib16">Coronel et al., 2012</xref>)</td></tr><tr><td valign="top">Hypertrophic cardiomyopathy phenotype</td><td valign="top">(<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>)</td></tr><tr><td valign="top">Drug safety prediction using populations of models</td><td valign="top">(<xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>)</td></tr><tr><td valign="top">Physiological QRS and QT intervals in ECG</td><td valign="top">(<xref ref-type="bibr" rid="bib25">Engblom et al., 2005</xref>; <xref ref-type="bibr" rid="bib81">van Oosterom et al., 2000</xref>; <xref ref-type="bibr" rid="bib4">Bousseljot et al., 1995</xref>; <xref ref-type="bibr" rid="bib31">Goldberger et al., 2000</xref>)</td></tr></tbody></table></table-wrap>